Baxter Kidney Patient Education Program Celebrates Tenth A... (available to you. Rogers says that t...)

Baxter Kidney Patient Education Program Celebrates Tenth Anniversary

Date:11/5/2007

available to you."

Rogers says that the information that she received from Vela gave her confidence and that she "didn't have to second guess or wonder if I made the right decision" when it came time for her to choose her treatment. But she also says that Vela provided something even more important.

"When you first find out that you have to go on dialysis you're terrified," said an emotional Rogers. "The most important thing she did was to take that fear away. She was there for me, she stayed there for me, and I know that even today I have someone that I can count on."

About Baxter

Baxter Healthcare Corporation is the principal U.S. operating subsidiary of Baxter International Inc. (NYSE: BAX). Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other conditions. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.

References

1. Rankin, S.H., & Stallings, K.D. (2001). Patient Education: Principles

and Practice. (4th ed). Philadelphia: Lippincott., 78-129.

2. Yeoh, et. al. (2003). Impact of predialysis care on clinical outcomes.

Hemodialysis International, 7(4), 338-341.

3. Klan, B. et. al. (1998) Predialysis patient education: effects on

functioning and well-being in uraemic patients. Journal of Advanced

Nursing, 28(1), 36-44

1

GOOD

Page: 1 2 3 4
Related biology technology :

1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
3. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
4. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
8. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
9. Aidas Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain

Post Your Comments:

Baxter Kidney Patient Education Program Celebrates Tenth A...(available to you. Rogers says that t...)